To further improve the development of custom endoprostheses in musculoskeletal oncologic limb-salvaging procedures, researchers began thorough analyses of failure modes for these prostheses, thus encouraging continuous redesign and improvement of endoprostheses.
The availability of endoprostheses for treating thoracic aortic pathology has not kept pace with those for treating abdominal aneurysms.
The most frequent complications of joint arthroplasty are septic or aseptic loosening of endoprostheses.
Both internal and external factors have an effect on the choice of endoprostheses in a hospital.
In March 2010, a hospital had to change 125 defect hip prostheses because cuttings of a special type of hip endoprostheses detached [ 4].
Our review details the history and development of endoprostheses throughout orthopedic oncology in the treatment of musculoskeletal tumors.
The use of endoprostheses in limb-salvaging procedures started to gain popularity in the 1970s as chemotherapy improved and total joint replacements were increasingly used.
In the beginning of the next decade, the booming supply of endoprostheses will still be a major issue.
Finally, the manufacturers of endoprostheses ought to take the learning effect into account when designing new devices.
In many studies regarding the medium- or long-term results of endoprostheses, the endpoint has been revision for any reason.
